←Back to Expert Scholars
Translational Medicine / 转化医学RNAseq Profiling, Breast Cancer
Philip Bernard
MD
🏢Huntsman Cancer Institute, University of Utah🌐USA
Professor of Pathology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Philip Bernard co-developed the PAM50 breast cancer classifier and the Prosigna assay with colleagues at UNC and Utah. He is a pathologist at Huntsman Cancer Institute. His work established intrinsic subtype based prognostic testing in breast cancer.
Share:
🧪Research Fields 研究领域
PAM50 development
Prosigna assay
breast cancer prognostics
molecular diagnostics
transcriptomics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Philip Bernard 的研究动态
Follow Philip Bernard's research updates
留下邮箱，当我们发布与 Philip Bernard（Huntsman Cancer Institute, University of Utah）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment